Supernus Pharmaceuticals Gross Profit 2011-2024 | SUPN

Supernus Pharmaceuticals gross profit from 2011 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.

Supernus Pharmaceuticals Gross Profit 2011-2024 | SUPN

Supernus Pharmaceuticals gross profit from 2011 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
Dr Reddy's Laboratories (RDY)$12.6B
BridgeBio Pharma (BBIO)$5.1B
Bausch Health Cos (BHC)$3.4B
Amphastar Pharmaceuticals (AMPH)$2.4B
Taysha Gene Therapies (TSHA)$307M
Personalis (PSNL)$241M
Assembly Biosciences (ASMB)$106M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$5M
Teligent (TLGT)$0M